BREAKING NEWS: FDA approves lotilaner ophthalmic solution 0.25% for treatment of Demodex blepharitis. Jul 25, 2023.
Opthea announces nonproprietary drug name “sozinibercept” for OPT-302
Share This Story, Choose Your Platform!
About the Author:
BREAKING NEWS: FDA approves lotilaner ophthalmic solution 0.25% for treatment of Demodex blepharitis. Jul 25, 2023.